Merger boosts Merck’s revenue
February 17, 2010Sales and Marketing MA, Merck
Merck’s merger with Schering-Plough in October has helped boost the company’s full year sales by 13% to $27.4 billion.The gain …
AstraZeneca signs deal with Rigel on RA treatment
February 17, 2010Research and Development AZ, Rigel, rheumatoid arthritis
AstraZeneca is looking to enter the lucrative rheumatoid arthritis market by in-licensing a phase II treatment.The global market for rheumatoid …
Dr Steven Leventer to head up neuroscience research for PharmaNet
February 17, 2010Research and Development PharmaNet, appointment, research and development
PharmaNet Development Group has named Dr Steven Leventer to the position of vice president, clinical research – neuroscience. Leventer joins …
Obituary – Cephalon’s Paul Jewsbury
February 17, 2010Medical Communications, Sales and Marketing Cephalon, appointment, medical communications, sales and marketing
Cephalon UK’s senior product manager Paul Jewsbury lost his long and hard-fought battle against a recurring brain tumour in December.Paul, …
Immatics vaccine trials to be conducted with Cancer Research UK
February 16, 2010Research and Development immatics, vaccines
Cancer Research Technology, the development and commercial arm of Cancer Research UK, has reached an agreement to collaborate with German-based …
Abbott completes Solvay acquisition
February 16, 2010Sales and Marketing Abbott, Solvay
Abbott has completed its $6.2 billion acquisition of Solvay’s pharma division.The acquisition is expected to add $2.9 billion to Abbott’s …
European Court supports ABPI’s prescribing incentives fight
February 16, 2010Sales and Marketing ABPI, prescribing incentives
The ABPI has come out on top in the opening salvo of its unprecedented European legal challenge against prescribing incentive …
Sights set on target setting?
February 16, 2010Sales and Marketing forecasts, sales
Research funded by the Chartered Institue of Management Accountants (CIMA) has helped Cranfield School of Management unveil a new framework …
GSK appoints Adrian Hodges
February 16, 2010Sales and Marketing GlaxoSmithKline, appointment, industry reputation, sales and marketing
GlaxoSmithKline has appointed Adrian Hodges to head up corporate responsibility and community partnerships. He moves to the pharma company after …
BMA hits out at NHS commercialisation
February 15, 2010BMA, NHS, private sector
The British Medical Association is urging the public to resist the role of private companies in the NHS. Its Look …
MDS completes contract research exit
February 15, 2010Research and Development CRO, mds
MDS has completed the sell-off of its contract research and development business – MDS Pharma Services – with the signing …
Novo to challenge NICE Victoza guidance
February 15, 2010Sales and Marketing NICE, Novo Nordisk, Victoza
NICE has given a partial green light to Novo Nordisk’s type II diabetes treatment Victoza, backing its use as part …
Sanofi expands cancer care campaign
February 15, 2010Sales and Marketing Sanofi-Aventis, charity
Sanofi-Aventis has expanded its My Child Matters programme, adding another seven new projects for improving cancer care for children in …
Amarin appoints Jan van Heek
February 15, 2010Research and Development, Sales and Marketing Amarin, appointment, research and development, sales and marketing
Jan van Heek has joined Amarin’s board of directors of as a non-executive director and will also take on the role …
Contract research news in brief
February 15, 2010Research and Development Almac Pharma Services, CRO, CoreLab Partners, DreamCIS, PPD, Parexel, Proteome Sciences, SIRO Clinpharm, Thermo Fisher Scientifitic
Our round-up of developments in the contract research sector includes alliances for Parexel/Proteome Sciences and SIRO Clinpharm/DreamCIS, as well as …
Langland aims to ‘Cake A Difference’
February 12, 2010Medical Communications Langland, charity
Langland has marshaled its digital and design teams in support of Bliss, producing a pro bono campaign for the premature …
Cephalon posts strong figures
February 12, 2010Sales and Marketing 2009 financials, Cephalon
US–based specialty pharma company Cephalon, best known for its sleep disorder treatment Provigil, has posted an 11% increase in sales …
Digital Pharma: The MHRA is a late guest at the information party
February 12, 2010Medical Communications MHRA, information, patient information
The MHRA is considering putting its database of patient information leaflets (PILs) and Summaries of Product Characteristics (SPCs) online and …
Ulcerative colitis market set to double by 2018
February 12, 2010Sales and Marketing Humira, Simponi, TNF, ulcerative colitis
The market for ulcerative colitis drugs is set to double over the ten years to 2018 when it will hit …
Obesity costs could hit £5bn by 2025
February 12, 2010NHS, obesity
A new review of UK health services has come up with half a dozen ways in which the government should …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
